RoslinCT is a UK-based GMP contract manufacturing organisation.
RoslinCT offers a range of integrated services from technology transfer, process and assay development through to GMP manufacturing, QP certification and batch release of cell-based therapies for clinical trials. RoslinCT engages with leading cell and gene therapy developers providing a personalised service to accelerate the path to market.
Originally founded in 2006 as a spin-out from the Roslin Institute, we built on the broad range of scientific expertise available in the field of cell biology. Investment in the field of regenerative medicine led to the creation of the Scottish Centre for Regenerative Medicine (SCRM) in Edinburgh, which now attracts international research and talent to the area. We established and validated GMP manufacturing facilities within SCRM in 2012 and continue to grow the GMP contract manufacturing business from this site.
RoslinCT uniquely combines the trusted resources in cell isolation, manufacture and characterisation, a mature quality management system and fully licenced GMP manufacturing facilities together with a passion for innovation and a flexible and personalised approach to support clients at every step of the cell therapy development journey.